Michele Babicky, MD
Surgical Oncology · Portland, ORNPI 1871742478
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,171 of the $3,755 with a category attached, or 84.5%. 12 manufacturers reported payments, led by Boston Scientific at 56.3% of the total. 2025 is the largest year on record at $2,225, more than ten times the $189 reported in 2019.
Across 36 payments — averaging $104.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Intera Oncology, Inc$556
- Biom'up France SAS$223
- Intuitive Surgical$173
- Genentech USA, Inc.$141
- Nestle Healthcare Nutrition Inc.$121
- plus $427 from 6 others
What the payments were for
- Travel & lodging$58416%
- Food & beverage$3,17184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $2,114 |
| Intera Oncology, Inc | 3 | $556 |
| Biom'up France SAS | 2 | $223 |
| Intuitive Surgical | 2 | $173 |
| Genentech USA, Inc. | 1 | $141 |
| Nestle Healthcare Nutrition Inc. | 6 | $121 |
| Microline Surgical Inc | 5 | $118 |
| Johnson & Johnson | 2 | $110 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Davol Inc. | 2 | $57 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| AbbVie | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few surgical oncology providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 20 | $217 |
| Oxycodone Hcl | 35 | $195 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Portland
- Rodney PommierPortland$24K
- Joshua DavisPortland$3K
- John VettoPortland$3K
- John CreasyPortland$3K
- Arpana NaikPortland$2K
- Kristen MassiminoPortland$2K
- Winifred LoPortland$449
- Dale HanPortland$238
- Divya SoodPortland$174
- Kelvin YuPortland$37
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.